Marshall Wace’s Clene CLNN Stock Holding History

Marshall Wace’s Portfolio CLNN Stock Details CLNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22,709	Closed	-$137K	–	3018
2025 Q3	$137K	Buy	+22,709	New	+$108K	﹤0.01%	2620
2022 Q1	–	Sell	-1,952	Closed	-$159K	–	3416
2021 Q4	$159K	Buy	+1,952	New	+$209K	﹤0.01%	3239

Other funds holding CLNN

SCP

SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM

Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LCM

Lunt Capital Management Holladay, Utah $260M AUM 10.98% 1-Year Est. Return

PEAK6 Chicago, Illinois $42.6B AUM 66.3% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace's CLNN Position: Q4 2025 in Review

Marshall Wace sold out of Clene (CLNN) in Q4 2025, closing a stake of 22,709 shares — an estimated $137K sold.

Marshall Wace first reported a position in CLNN in Q4 2021 and held it in 2 quarters. The position peaked at $159K in Q4 2021. 28 funds tracked by Wall St. Rank hold CLNN as of Q4 2025.

Marshall Wace reported no remaining Clene position as of Q4 2025 after selling out during the quarter.
Marshall Wace sold 22,709 Clene shares in Q4 2025, an estimated $137K.
Marshall Wace first reported a position in Clene in Q4 2021 and held it in 2 quarters.
Marshall Wace's Clene position peaked at $159K in Q4 2021.
28 funds tracked by Wall St. Rank held Clene as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.